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Abstract
Pseudorabies virus (PRV) infection in animals other than its natural host almost always gives rise to fatal diseases in the central nervous
system as a result of infection of peripheral neurons and subsequently to the brain. PRV immediate-early protein (IE180) activates
transcription of the PRV early and late genes, and other viral and cellular genes, and represses its own transcription. To examine specific
effects of IE180 in neuropathogenicity, we have generated four transgenic mouse lines expressing IE180 in a tetracycline-regulated system.
In the transgenic mouse lines, cerebellar symptoms such as ataxic gait, tremor and motor discoordination were observed. Histopathology
of the cerebella in the transgenic mouse lines showing severe symptoms was remarkable for a failure of layer formation and a reduction
in cerebellar size. These findings suggest that IE180 affects the cascade of gene expression for development of the murine cerebellum,
resulting in the impairment of the cerebellar development and differentiation.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Pseudorabies virus (PRV) is classified into the genus
Varicellovirus of subfamily Alphaherpesvirinae (Kit, 1994).
PRV causes severe disease including nervous signs such as
unbalanced stepping, trembling, staggering, and convul-
sions in piglets, and acute fatal infections in other animals.
PRV invades and spreads within the trigeminal pathway
(the nasal mucosa, the trigeminal ganglion, the pons/me-
dulla, and the cerebellum/thalamus) of neonatal pigs (Kritas
and Pensaert, 1994; Kritas et al., 1994). It induces enceph-
alitis in both pigs and mice with similar pathological signs
(van Oirschot et al., 1990).
During mouse embryogenesis, the cerebellum arises as a
very complex outgrowth on the dorsal side of the metenceph-
alon. Cerebellar ontogenesis is characterized by directional
migration, differentiation, and synaptogenesis with a precise
spatiotemporal order of positioning, leading to three highly
organized cellular layers. Proliferating cerebellar neuroepithe-
lial cells migrate from the ventricular zone to populate the deep
cerebellar nuclei and Purkinje cell layers (Hatten, 1999). Post-
natal differentiation of Purkinje cells leads to the development
of an extensive dendritic arbor in the molecular layer, which is
located at the exterior of the adult cerebellum (Takacs and
Hamori, 1994). The cerebellum undergoes considerable post-
natal granule neuron migration using a radial glial cell scaf-
folding (Hatten, 1999). Granule cells migrate from the external
granule cell layer through the molecular and Purkinje cell
layers to the internal granule cell layer. In the adult cerebellar
cortex, bushy astrocytes and radial Bergmann glial cells are
distributed throughout both the internal granule layer and Pur-
kinje cells, respectively. During cerebellar development, neu-
ronal cell migration to the cortical laminar layers is guided by
radial and Bergmann glial cell processes (Hatten, 1999). The
cell adhesion receptor systems involved in this neuronal cell
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migration include the netrin receptors, the erbB receptors, the
integrin family and the cadherin family (Rakic et al., 1994).
Transcription factors of alphaherpesviruses are not only
important for their viral gene expression, but also participate
in the cellular gene expression of their host. It was reported
that overproduction of an alphaherpesvirus transcription
factor such as ICP0 of HSV-1 or blCP0 of BHV-1 in the
absence of other viral genes resulted in marked toxicity in
cultured cells (Hobbs et al., 2001; Inman et al., 2001). PRV
is known to be a neurotropic virus, and infection in animals
other than its natural host gives rise to fatal diseases in the
central nervous system as a result of infection of peripheral
neurons and subsequently the brain. PRV expresses a single
IE protein (IE180), with a molecular weight of 180 kDa, for
continuous transcription of late genes and shutting off the
synthesis of its own RNA (Green et al., 1983; Ihara et al.,
1983; Wu and Berk, 1988). In addition, IE180 is known as
a strong transactivator of several promoters, including other
viral and cellular genes (Green et al., 1983; Wong et al.,
1997; Wu and Berk, 1988; Yuan et al., 1989), and binds to
specific sites on class II gene promoters (Cromlish et al.,
1989) and single-stranded DNA (Chlan et al., 1987). Taken
together, these findings suggest the possibility that IE180 is
not only important for the viral gene expression, but also
participates in the cellular gene expression of the host cells,
including neuronal cells in the central nervous system. It is
therefore important to assess the neuropathogenic potential
of PRV IE180 in the absence of other viral proteins.
The work presented here describes the role of IE180 in
neuropathogenicity in vivo. We generated several trans-
genic mouse lines expressing IE180 in a tetracycline-
regulated system. We observed that IE180 impaired cer-
ebellar development and that transgenic mice showed
symptoms such as ataxic gait, tremor, and motor disco-
ordination.
Results
Generation of transgenic mice
To assess the neuropathogenic potential of pseudorabies
virus IE180, four transgenic mouse lines expressing the
IE180 gene in a tetracycline-regulated system (Tet-Off Sys-
tem; Fig. 1) were generated. The tetracycline-regulated sys-
tem (Shockett et al., 1995) was used for controlling the
IE180 gene expression, since IE180 might be toxic to ani-
mals. Southern blot analysis performed on genomic DNA
from these mice showed that the intensity of each transgene
was different among the transgenic mice. The results indi-
cated that the lines varied in transgene copy number (2
copies for TgIE52, 16 copies for TgIE68, 4 copies for
TgIE96, and 28 copies for TgIE102; Fig. 2). Since male
mice of the TgIE52 line were sterile, heterozygote mice
were used for further characterization of the transgenic
mouse line.
Expression of the transgenes in transgenic mice
The expression of the transgenes in various tissues of
adult transgenic mouse was assessed by utilizing the RT-
PCR method, since we could detect neither IE180 mRNA
by Northern blot analysis nor IE180 by Western blot anal-
ysis. The tested tissues included skin, skeletal muscles,
heart, lung, small intestine, spleen, liver, kidney, cerebrum,
cerebellum, trigeminal nerve, and testis. In the four trans-
genic mouse lines, the expected 296-bp PCR product for
IE180 mRNA was detected in almost all of the tested tissues
except liver. The expression level of the transgene varied
substantially between the tested tissues, with expression
consistently high in cerebrum and cerebellum, and low in
lung. A representative result of the IE180 gene expression in
the TgIE52 line is shown in Fig. 3 and expression of the
IE180 gene in various tissues of the transgenic mouse lines
is summarized in Table 1. For the tTA gene expression,
similar expression patterns were observed (data not shown).
To compare expression levels of the transgene among the
transgenic mouse lines, IE180 and tTA mRNAs in the
cerebellum of each transgenic mouse were measured by the
quantitative RT-PCR method. Each cDNA was synthesized
from the total RNA from the cerebellum 24 h after removal
of tetracycline. RT-PCR analysis using serially diluted
cDNA samples was performed. As shown in Fig. 4 and
Table 2, relatively high-level expression of the transgenes
was observed in a transgenic mouse lines TgIE96 and
TgIE52, although the TgIE52 line was a heterozygote. In
contrast, the expression levels in the TgIE68 and the
TgIE102 lines were significantly low as compared with
those of the high-expression lines.
To confirm the inducible expression in cerebellum, high-
expression line TgIE52 was screened for inducibility by
measuring IE180 and tTA mRNA levels in the cerebellum
24 h after removal of tetracycline, using the quantitative
RT-PCR method. As shown in Fig. 5, both mRNAs were
detected in the transgenic cerebellum in the presence of
tetracycline. Removal of tetracycline resulted in higher ex-
pression levels of the transgenes (2-fold for both IE180
mRNA and tTA mRNA). There was an obvious correlation
between expression of the IE180 gene and the tTA gene.
To examine whether IE180 expression level changed in
early postnatal stages, quantitative RT-PCR analysis using
cerebella of the TgIE96 line was performed. There was no
difference in the levels of the IE mRNA accumulation
among the cerebella at postnatal days 0, 9, 14, and 21 (data
not shown).
Expression of PRV IE180 in transgenic mice induces
characteristic cerebellar symptoms
In the course of breeding both of the TgIE52 and TgIE96
lines that expressed the transgene at relatively high levels,
we observed that the transgenic mouse lines had character-
istic symptoms such as locomotor ataxia, tremor and motor
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discoordination. The symptoms in TgIE52 and TgIE96 lines
were observed even in the presence of tetracycline, indicat-
ing that the leakiness of the transgene expression shown in
Fig. 5 was enough to induce the cerebellar symptoms. In
addition, some of the transgenic mice of TgIE68 (6 of 73
mice) and TgIE102 (3 of 43 mice) showed similar symp-
toms such as ataxic gait, hunched posture, hind-limb weak-
ness and motor discoordination in the presence of tetracy-
cline. These results may indicate a correlation between the
expression level of the IE180 gene and the cerebellar symp-
toms. Characteristics of the transgenic mouse lines are sum-
marized in Table 2.
Motor deficits in the IE180 transgenic mice
To assess in more detail the motor deficits of the trans-
genic mice, the IE180 transgenic and control mice were
subjected to two tests of motor behavior. Gait abnormalities
were examined by the footprint test. Footprint patterns of a
wild-type mouse and a transgenic mouse of the TgIE96 line
at 8 weeks of age are illustrated in Fig. 6. The control mouse
walked in a straight line, with a regular even alternating
gait, placing the hindpaw precisely at the position where the
ipsilateral forepaw had been in the previous step (Fig. 6A).
By contrast, the IE180 transgenic mouse could not walk in
a straight line like the wild-type mouse and showed a gait
that lacked a normal, uniform, alternating left-right step
pattern (Fig. 6B). The transgenic mouse walked with a
wide-base rolling motion from side to side. Its steps ap-
peared to be shorter, and the feet tended to sweep along.
Similar footprint patterns were obtained for other transgenic
mice of the TgIE96 line and also the transgenic mice of the
TgIE52 line.
Motor coordination and balance of mice were measured
Fig. 1. Schematic representation of the transgene fragments. A) Schematic diagram of the PRV genome and KpnI restriction map. The genome is organized
into unique long (UL), internal repeat (IR), unique short (US) and terminal repeat (TR) sequences. Below, the genome is shown as an expanded diagram of
the KpnI-E fragment and its BamHI restriction map. The arrow indicates the direction of the IE180 gene transcription. B) The transgene contains the Tet
promoter, the PRV IE180 gene (4.8-kb) and the SV40 intron/polyA signal. The IE180 gene is under the control of the Tet promoter. Locations of the primers
(IE-F and IE-R) used for the PCR method and the expected sizes of amplified products are shown. Cleavage sites for restriction enzymes HindIII and EcoRI
are indicated. C) The tTAk gene is under the control of the Tet promoter. Locations of the primers (Tet-F and pA-R) used for the PCR method and the
expected sizes of amplified products are shown. Cleavage sites for restriction enzymes XhoI and NotI are indicated.
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using a rotarod. All mice used in this test showed learning
of the rotarod test and reached a stable level of performance.
Throughout the test control mice maintained balance on the
rotarod for more than 200 sec. Transgenic mice of the
TgIE52 and TgIE96 lines had difficulty maintaining balance
on the rotarod. The significance of the difference between
the performance of the transgenic and control mice was
confirmed by statistical analysis (TgIE52; P  0.0125,
TgIE96; P  0.001) (Fig. 7). In addition, a significant
difference was observed when mice of the TgIE68 line
showing the cerebellar symptoms were tested by the ro-
tarod, but not for the transgenic mice showing no symptoms
(Fig. 7).
Histopathological analysis of the transgenic cerebellum
The TgIE52 and TgIE96 lines were used for histopatho-
logical characterization of this phenotype. Gross anatomi-
cally, the overall size of the cerebellum of each adult trans-
genic mouse was reduced. Histological study with
hematoxylin and eosin showed no abnormality of pheno-
typic appearance in any organ except the cerebellum (Figs.
8A, 8B and 8C). Histological staining demonstrated that
each transgenic cerebellum displayed a disorganization of
the molecular, Purkinje cell and internal granule layers,
suggesting defective neuronal migration during cerebellar
morphogenesis (Figs. 8D, 8E and 8F). In all mice of the
TgIE52 and TgIE96 lines tested, similar histopathological
characterization was observed. In other parts of the brain
Fig. 2. Southern blot analysis of the introduced transgene in four transgenic
mouse lines. Genomic DNA was prepared from the tails of transgenic mice
and digested with EcoRI. The samples were electrophoresed on 0.8%
agarose gel. Copy numbers of control DNA derived from pTet/IE180 are
shown in the right four lanes. Molecular weight markers are shown on the
left. Arrow on the right indicates the position of the 4.8-kb EcoRI fragment
containing the IE180 gene. The copy numbers of the transgene integrated
in the genomic DNA are shown below the figure.
Fig. 3. Expression of the IE180 gene in various tissues of the transgenic
mouse line TgIE52. Representative result of Southern blot analysis using
RT-PCR products from various tissues is shown. Total RNA prepared from
various tissues was analyzed by the RT-PCR method. The control exper-
iments (RT-) were performed without MMLV reverse transcriptase to
confirm the absence of genomic DNA contamination. Lanes, the RT-PCR
product from skin (1), skeletal muscles (2), heart (3), lung (4), small
intestine (5), spleen (6), liver (7), kidney (8), cerebrum (9), cerebellum
(10), trigeminal nerve (11) and testis (12). : Positive control product
synthesized from the transgene DNA fragment by the PCR method. :
Control RT-PCR reaction without MMLV reverse transcriptase.
Table 1
Expression of the IE180 gene in various tissues of the transgenic mouse
lines
Tissues Expression of the IE180 genea
TgIE52 TgIE68 TgIE96 TgIE102
Skin    
Skeletal muscles    
Heart    
Lung    
Small intestine    
Spleen    
Liver    
Kidney    
Cerebrum    
Cerebellum    
Trigeminal nerve    
Testis    
a Expression of the IE180 gene was identified by Southern blot analysis
using RT-PCR products.
Fig. 4. Quantitative RT-PCR analysis of the transgene expression in the
transgenic mouse lines. Total RNA was harvested from the cerebellum of
each transgenic mouse with induction, and 1 g of each sample was
reverse transcribed by reverse transcriptase using oligo (dT). Five-fold
serial dilutions of each cDNA sample were amplified with the PCR method
using the IE-F/IE-R primer pair for the IE180 gene, the Tet-F/pA-R primer
pair for the tTA gene or the TK35/TK36 primer pair for the -actin gene.
-actin mRNA was used as a control.: Control RT-PCR reaction without
MMLV reverse transcriptase. IE180 transcript levels of the transgenic lines
TgIE96 and TgIE52, which always displayed cerebellar symptoms, were
higher than transgenic lines TgIE68 and TgIE102.
246 S. Taharaguchi et al. / Virology 307 (2003) 243–254
such as the hippocampus and the cerebral cortex, no abnor-
mality was observed in the transgenic mouse lines (Figs.
8G, 8H, 8I and 8J). In contrast, no abnormality was found in
the cerebella of two other transgenic mouse lines, even in
transgenic mice of the TgIE68 and TgIE102 lines showing
symptoms (data not shown). IE180 in the cerebella of the
adult transgenic mice could not be immunohistochemically
stained by anti-IE180 antisera. This might indicate that
IE180 accumulation was considerably low in the cerebella
of the adult transgenic mice.
To further study the disruption in cerebellar morphogen-
esis, distinct cellular layers of the postnatal cerebellum were
analyzed by immunohistochemical staining using antisera
against two different cell-specific marker proteins. Astro-
cytes and activated Bergmann radial glial cells were de-
tected with a glial fibrillary acidic protein (GFAP) antibody
(Hewicker-Trautwein and Trautwein, 1993), and Purkinje
cells were detected with a calbindin antibody (Celio, 1990).
Immunohistochemical staining of the wild-type cerebellum
with the anti-GFAP antibody detected the bushy astrocytes
in the granule layer and the radial Bergmann glial cell
bodies in the Purkinje cell layer, from which they extended
radial processes into the molecular layer (Fig. 9A). By
contrast, the bushy astrocytes and the Bergmann glial cells
were disorganized in the transgenic cerebellum (Fig. 9B).
Immunohistochemical staining of the wild-type cerebellum
with anti-calbindin showed the precise alignment of the
Purkinje cell layer and the branching Purkinje cell dendrites
facing toward the cerebellar surface in the molecular layer
(Fig. 9C). By contrast, the transgenic cerebellar cortex
lacked clearly defined laminar cell layers, the Purkinje cell
bodies were randomly oriented, and they displayed imma-
ture dendritic arbor (Fig. 9D). These data suggested that the
IE180 transgene expression disrupted astrocyte cytoarchi-
tecture and function, which is critical for neuronal migration
and terminal differentiation, and impaired maturation of the
Purkinje cell dendritic arbor.
Analysis of expression of cerebellar genes consistent with
the cerebellar phenotype
Quantitative RT-PCR analysis of several cerebellar
genes was used to identify cerebellar genes whose altered
expression was consistent with the transgenic cerebellar
phenotype. The cerebellar genes included the brain lipid-
binding protein (BLBP) the D-amino acid oxidase (DAO)
gene, the insulin-like growth factor binding protein-1 (IG-
FBP-1) gene and the tenascin gene. The quantitative RT-
PCR analysis revealed that the transgenic cerebellum of the
TgIE96 line displayed an approximately 80% reduction of
DAO gene expression as compared with the wild-type cer-
ebellum (data not shown). However, for other genes, altered
expression was not observed in the transgenic cerebellum.
In addition, no difference among all of the genes tested was
displayed at postnatal day 0. Although the genes tested were
limited and the RNA samples were prepared at postnatal
day 0 or 9, this observation indicated that diminished ex-
pression of the DAO gene at postnatal day 9 might influence
Purkinje cell maturation in the transgenic cerebellum.
Discussion
Transgenic mouse lines expressing IE180 showed the
cerebellar symptoms such as ataxic gait, tremor, and motor
discoordination. The most severe histological phenotype
Table 2
Characteristics of IE180 transgenic mouse lines
Mouse line Status Copy number
of transgene
Transgene
expressiona
Cerebellar symptoms
ataxic gait motor discoordination tremor
TgIE52 Heterozygoteb 2 26   
TgIE68 Homozygote 16 3 /c /c 
TgIE96 Homozygote 4 45   
TgIE102 Homozygote 28 1 /d NTe 
a Transgene expression data were measured as described in Materials and methods. Expression level of TgIE102 was estimated 1 grade.
b Heterozygote mice were used for the experiments, since homozygote was not born by reason of the sterility of the male mice.
c Ataxic gate and morter discoordination were observed in 6 of 73 transgenic mice.
d Ataxic gate was observed in 3 of 43 transgenic mice.
e Not tested.
Fig. 5. Detection of the transgene mRNA expression enhanced by the
tetracycline-inducible system. A transgenic mouse of the TgIE52 line was
screened for inducibility by measuring IE180 and tTA mRNA levels in the
cerebellum at 24 h after removal of tetracycline using the quantitative
RT-PCR method. The quantitative RT-PCR analysis was performed as
described in Fig. 4. -actin mRNA was used as a control. Tet (): The
transgene expression in presence of tetracycline (100 g/ml). Tet (): The
transgene expression in absence of tetracycline. : Control RT-PCR re-
action without MMLV reverse transcriptase.
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Fig. 6. Footprint patterns of a wild-type mouse (A) and a transgenic mouse of TgIE96 line (B). The transgenic mouse showed ataxic gait and could not walk
along a straight line like wild-type mouse.
Fig. 7. Balance and motor coordination on the rotarod. Mice of the wild type (n 3), TgIE52 (n 4), TgIE96 (n 3), TgIE68 showing cerebellar symptoms
(n  3) and TgIE68 showing no symptom were tested on the rotarod (20 rpm/min). The duration of latency to falling off for three trials was recorded. The
IE180 transgenic mice had difficulty maintaining balance on the rotarod. Values indicate the means  SD. Asterisks indicate significant differences (P 
0.05) between the wild-type and the IE180 transgenic mice (TgIE52; P  0.0125, TgIE96; P  0.001, TgIE68 showing cerebellar symptoms; P  0.031).
Fig. 8. Histological analyses of the brains of the IE180 transgenic mouse lines. Hematoxylin and eosin stained cerebellum in sagittal section. Cerebellum of
a wild-type control mouse (A and D), and transgenic mice of TgIE52 (B and E) and TgIE96 lines (C and F). The expression of IE180 in the cerebella elicits
defects in the cerebellar size and the cellular organization. The transgenic cerebellum failed to be organized into a typical three-layered structure (B and C).
High magnification of the transgenic cerebella displays the disorganization of the molecular, Purkinje cell and internal granule layers (E and F). Hippocampus
and cerebral cortex of a wild-type control mouse (G and I) and a transgenic mouse of TgIE52 line (H and J). The hematoxylin and eosin staining showed
that no abnormality was found in the orderly six-layered structure of the cerebral cortex and the hippocampal cytoarchitecture in the transgenic mouse. Scale
bars: 1 mm in A–C, 100 m in D–F, 500 m in G and H, 200 m in I and J.
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among the transgenic mice exhibited the impairment of the
cerebellar development, including a failure of layer forma-
tion and a reduction in cerebellar size. These cerebellar
defects were not due to the integration site of the transgene,
because two transgenic lines had the same phenotype. In
addition, the expression level of IE180 correlated with the
phenotype. It is known that expression of the tTA protein in
vivo is not toxic (Shockett et al., 1995). These results
suggested the neuropathogenic potential of PRV IE180 in
the absence of other viral proteins.
The cellular organization and neural circuit of the mouse
cerebellum develop through a series of cellular events, all of
which occur serially and precisely according to a develop-
mental schedule. Expression profiles of gene groups respon-
sible for these events should match the corresponding
stages. In the cerebella of the transgenic mice, inhibition of
the migration of granule cells and Purkinje cells resulted in
disorganization of the molecular, Purkinje cell and internal
granule layers. Radial glial and Bergmann glial cells pro-
vide a scaffold for the migration of granule cells and Pur-
kinje cells from their sites of origin to their final destina-
tions, indicating that radial glial and Bergmann glial cells of
the IE180 transgenic mice had functional defects. They
failed to assemble into radial glial scaffolding, leading to
abnormal neuronal migration to the laminar cell layers.
Radial glial cells can be recognized by the expression of the
cell markers brain lipid-binding protein (BLBP) and RC2
(Hunter and Hatten, 1995). BLBP has been shown to be a
fundamental protein of the radial glial cells and an important
marker of this early phase of the glial cell development so
critical for cell migration (Feng et al., 1994; Xu et al., 1996).
The expression of BLBP by Bergmann glial cells supports a
role for BLBP in signaling events needed for expression of cell
properties that support migration (Feng et al., 1994). The ex-
pression of BLBP is induced by the neuronal growth factor
GGF (glial growth factor), or neuregulin, an inducer of the
radial glial phenotype (Anton et al., 1996). The neuronal pro-
tein RF60 is abundant in the mid-gestational period when
migration is robust, decreasing in later periods when migration
wanes, and undetectable in the adult, after the program of
migration has established the neuronal laminae (Hunter and
Hatten, 1995). Although no difference between the expression
levels of BLBP mRNA in the TgIE96 line and the wild type
was observed at postnatal day 0, the expression of these pro-
teins (including prenatally expressed BLBP) that contribute to
the formation of the radial glial scaffold might be affected by
IE180 in the transgenic cerebellum. The altered expression of
these proteins might result in the failure to assemble the radial
glial scaffold.
The cell adhesion receptor systems are also involved in
neuronal cell migration (Rakic et al., 1994). Integrin 5 and
ErB4 receptor genes are transiently expressed during radial
glial-guided neuronal migration during cerebellar morpho-
genesis (Hirsch et al., 1994; Rio et al., 1997). Tenascin
plays an important role in the regulation of granule cell
migration in the developing cerebellum (Erickson, 1993).
Tenascin, which possesses neuron-glial adhesiveness, is
also expressed on the radial fibers during the migration of
Purkinje cells (Yuasa et al., 1991). However, we could not
find any difference between the tenascin mRNA levels in
the transgenic and wild-type mice at postnatal day 9. If
IE180 transactivates the expression of these genes associ-
ated with the neuronal migration period of cerebellar for-
mation, the IE180 induced, abnormally protracted expres-
sion of these genes results in disorganization of the
molecular, Purkinje cell, and internal granule layers.
Reduction in cerebellar size was observed in the IE180
transgenic mice. The homeodomain engrailed-2 (En-2) tran-
scription factor is required for proper cerebellar morphogenesis
and foliation. Although En-2/ mice did not exhibit ataxia,
they displayed a reduction in cerebellar size and a distinct
patterning defect of the cerebellar folia (Joyner et al., 1991;
Millen et al., 1994). Reduced expression of En-2 caused by
IE180 in the transgenic mice may contribute to the observed
foliation defects and the reduction in cerebellar size. Trans-
genic mice ectopically expressing insulin-like growth factor
binding protein-1 (IGFBP-1) in the developing brain displayed
a 60% reduction in postnatal brain growth (D’Ercole et al.,
1996). However, induced expression of IGFBP-1 was not
observed in the cerebellum of the TgIE96 line. It is therefore
unlikely that IGFBP-1 influenced the cerebellar size of the
transgenic mice expressing IE180.
Maturation of the Purkinje cell dendritic arbor, which re-
quires formation of parallel fiber synapses in the molecular
layer (Goffinet, 1990), was reduced in the transgenic cerebel-
lum (Fig. 9D). Ataxia telangiectasia (ATM) is caused by im-
proper development of the Purkinje cell dendritic arbor. The
phenotype of ATM-deficient mice displayed ataxia resulting
from neuronal degeneration and inhibition of the Purkinje cell
dendritic arbor maturation (Borghesani et al., 2000). The D-
amino acid oxidase (DAO) gene expressed in astrocytes and
Bergmann glial cells (Horiike et al., 1987) may affect the
maturation of the Purkinje cell dendritic arbor in the transgenic
mice. We observed a repressed level of DAO gene expression
in the TgIE96 line. This defect might influence neuronal trans-
mission because DAO is required for degradation of D-amino
acids, which may lead to prolonged stimulation of the N-
methyl-D-aspartate (NMDA) receptor (Mothet et al., 2000).
Treatment of chick embryos with the NMDA receptor antag-
onist NPC 12626 resulted in a 19% reduction in Purkinje cell
dendritic tree area and a 13% reduction in the number of
dendritic branch points (Vogel and Prittie, 1995). The reduc-
tion of DAO expression in the transgenic cerebellum may
therefore exacerbate the defect in Purkinje cell maturation.
Approximately 10% of the transgenic mice of TgIE68
and TgIE102 lines showed the cerebellar symptoms without
any abnormality in histopathological analysis. These find-
ings suggest that IE180 expression in the transgenic cere-
bellum causes not only a failure of layer formation and a
reduction in cerebellar size, but also impairment of neuronal
transmission and cerebellar function. In these cases, it was
considered that expression levels of IE180 were rather low
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and the cerebellar morphogenesis was not severely disrupted.
Thus, a low level of IE180 expression may influence neuronal
transmission and/or neuronal signal transduction. For example,
altered expression of sodium- and calcium-activated channels
in Purkinje cells affects neuronal transmission and cerebellar
function (Kohrman et al., 1996). Moreover, calcium/calmod-
ulin-dependent protein kinase IV (CaMKIV)-deficient mice
exhibit impairments of neuronal cAMP-responsive element
binding protein (CREB) phosphorylation and CREB transcrip-
tional activation (Ho et al., 2000). A decrease in CaMKIV
expression may lead to diminished neuronal signal transduc-
tion in the transgenic cerebellum. PRV infects the nasal mu-
cosa and then invades and spreads within the trigeminal path-
way containing the cerebellum of the neonatal pig (Kritas and
Pensaert, 1994; Kritas et al., 1994). Since IE180 is expressed
immediately after the viral infection, PRV infection in the
cerebellum may affect the neuronal transmission and/or the
neuronal signal transduction, even when viral replication is
inhibited. The mechanism for the spontaneous appearance of
transgenic mice (TgIE68 and TgIE102) exhibiting the cerebel-
lar symptoms is unclear. The genetic background of each
transgenic mouse may have caused the phenotypic differences,
since these transgenic founders were obtained from B6C3F1
(C57BL/6  C3H/He) mouse embryos.
Considering all of the above, the pathological changes
found presumably resulted from the primary effect of IE180
in radial glial and Bergmann glial cells in the prenatal
and/or postnatal stages. It was thought that the neuronal
abnormalities were due to secondary migration abnormali-
ties induced by the disruption of these guidance cells. The
fact that mice from TgIE68 and TgIE102 lines (which had
the lowest IE180 expression levels) showed clinical evi-
dence of cerebellar dysfunction in the absence of overt
cerebellar pathology suggested that there was also some
degree of primary neuronal dysfunction. Delaney et al.
(1996) reported that treatment of transgenic mice expressing
HSV-thymidine kinase under the control of the GFAP pro-
moter with ganciclovir during the early postnatal period
results in ataxia and cerebellar defects, including disruption
of astrocyte development, ectopical distribution of Purkinje
cells and their abnormal dendritic trees. These findings
suggest the possibility that the primary effect of IE180 is on
radial glial and Bergmann glial cells. The fact that expres-
sion of the DAO gene in astrocytes and Bergmann glial cells
is diminished in the transgenic mouse expressing IE180
suggests that the reduction influences maturation of Pur-
kinje cells. Since the Purkinje cell dendritic arbor requires
formation of parallel fiber synapses in the molecular layer
(Goffinet, 1990), the reduced maturation of the Purkinje cell
dendritic arbor is likely to inhibit molecular layer synapto-
genesis between the granule cell parallel fiber axons and the
Purkinje cell dendrites. It is therefore considered that the
inhibition of synaptogenesis is one of the indirect effects of
IE180 and results in disruption of cerebellar neuronal cell
migration as one of the indirect effects.
Expression of the IE180 gene was detected only by
utilizing the RT-PCR method. We could detect neither
IE180 mRNA by Northern blot analysis nor IE180 polypep-
tide by Western blot analysis and immunohistochemistry in
the cerebella of the adult transgenic mice, indicating that
IE180 accumulation was considerably low. A possible ex-
planation for these results is that IE180 is toxic to cells and
the expression is tightly controlled through a negative au-
toregulatory mechanism in vivo. Similar findings were re-
ported in transgenic mice expressing viral transcription fac-
tors (Ono et al., 1999; Taharaguchi et al., 2002). It is
considered that embryos expressing high levels of IE180
could not survive and only low-expression mice were ob-
tained. Alternatively, a detectable level of IE180 polypep-
tide that is able to affect the cerebellar development may be
expressed transiently at some time during the cerebellar
development, although we cannot exclude the possibility
that IE180 mRNA acts as a pathogenic mRNA and alters
host cell function.
IE180 is a multifunctional transcription factor that acti-
vates transcription from a variety of promoters and re-
presses transcription from its own promoter. It is considered
that IE180 affects the serially and precisely regulated gene
expression needed for cerebellar development and up- or
down-regulates the various genes discussed above, resulting
in disruption of cerebellar morphogenesis. As another func-
tion, it is known that expression of IE180 leads to inhibition
of cellular protein synthesis (Ihara et al., 1983). However, it
is unlikely that this function is concerned with the disrup-
tion of cerebellar morphogenesis. No histological abnormal-
ity was observed in other tissues, including the cerebrum,
with expression consistently high, although the IE180 tran-
scripts were detected in almost all of tissues tested. If
cellular protein synthesis in those tissues was inhibited
nonspecifically, histological abnormalities should be ob-
served in tissues other than the cerebellum.
In summary, we described the characterization of a se-
vere cerebellar phenotype in IE180 transgenic mice result-
ing from expression of the IE180 transgene in the develop-
ing mouse cerebellum. IE180 transgene expression
impaired the formation of the radial glial scaffolding, re-
sulting in abnormal neuronal migration and organization of
the transgenic cerebellar cortex. The transgenic cerebella
also displayed defects in maturation of the Purkinje den-
dritic arbor and extension of the radial glial processes, thus
leading to diminished foliation. These transgenic mice will
therefore provide us with an experimental cerebellar devel-
opmental system in which to identify neuronal genes that
play critical roles in the cerebellar morphogenesis.
Materials and methods
Construction of the transgene
The EcoRI linker was inserted into the HindIII site end-
filled with a large fragment of DNA polymerase I to obtain
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a EcoRI fragment containing the PRV IE gene (Fig. 1A)
from pG/IE (Taharaguchi et al., 1994). The HindIII linker
was inserted into the blunt-ended XhoI and BstXI sites,
respectively, to disrupt the two sites in pTet-Splice (Invitro-
gen, Grand Island, NY) containing the Tet promoter, an
intron and polyadenylation signal from SV40. This modi-
fied plasmid was linearized at the single EcoRI site at the
junction between the promoter and the SV40 intron/polyA
signal. The linearized plasmid and the EcoRI fragment
containing the PRV IE gene were ligated. The resulting
plasmid was designated pTet/IE180. The 7.2-kb HindIII
fragment containing the Tet promoter, the PRV IE180 gene,
and the SV40 intron/polyA signal (Fig. 1B) from pTet/
IE180 was used for microinjection as a transgene.
Generation of transgenic mice
The 7.2-kb HindIII transgene fragment and the 3.3-kb
XhoI-NotI fragment containing the Tet promoter, the tetra-
cycline transactivator (tTA) gene, and the SV40 intron/
polyA signal from pTet-tTAk (Invitrogen) were isolated and
purified. Approximately 500 copies of each fragment in the
presence of 0.5 g of tetracycline per ml were comicroin-
jected into the pronuclei of fertilized B6C3F1 (C57BL/6 
C3H/He) mouse embryos. These embryos were subse-
quently transplanted into the oviducts of pseudopregnant
foster recipient mice that were provided with water contain-
ing 100 g of tetracycline per ml and 5% sucrose. Genomic
DNA was isolated from the mouse tail (Hogan et al., 1986).
Both transgenes were detected by PCR analysis using spe-
cific primers for the IE180 gene (IE-F: 5-AGA CCG AGG
GCA ACT TCA GC-3 and IE-R: 5-CGT CTT CGT CGT
CTA GCA CC-3; Fig. 1B) and for the tTA gene (Tet-F:
5-CGA AAA ACA ATT ACG GGT C-3 and pA-R: 5-
CGT AGC ACC AGG GGT TTAAGG-3; Fig. 1C). The
PCR reaction for the IE180 gene was carried out in a 50 l
final volume that included 1  PCR buffer (TAKARA,
Ohtsu, Japan), 1.5 mM MgCl2, 200 M of each dNTPs,
0.25 M of each primer, 10% DMSO and 2.5 U of Taq
DNA polymerase (TAKARA). The PCR reaction for the
tTA gene was carried out in the same reaction mixture
without DMSO. Thirty cycles of amplification were carried
out at 94°C for 45 sec, annealing at 58°C for 30 sec and
extension at 72°C for 90 sec. The PCR products were
fractionated on 1.5% agarose gel. The transgenic copy num-
ber was estimated by comparing the band intensity of trans-
genic mouse DNA with those of control DNA in Southern
blot analysis. The DNA samples (10 g) were digested with
EcoRI, fractionated on 0.8% agarose gel, and transferred to
Hybond N membranes (Amersham Pharmacia Biotech,
Uppsala, Sweden) by capillary blotting. Digoxigenin (DIG)-
labeled DNA probes for detection of the transgene were
derived from pTet/IE180 using the specific primers and a
PCR DIG probe synthesis kit (Roche Diagnostics, Mann-
heim, Germany). Hybridization and detection of the trans-
gene were performed as described previously (Ono et al.,
1999).
Analysis of the transgene expression
Transgenic mice (8 weeks old) were killed by decapita-
tion, and tissue samples were immediately removed and
frozen in liquid nitrogen. Total cellular RNA was isolated
from various tissues of the transgenic mice using TriZOL
reagent (Invitrogen) 24 h after removing tetracycline to
induce the transgene expression. For RT-PCR analysis, one
microgram of total RNA was digested with RNase-free
DNaseI (Invitrogen) to remove any contaminating genomic
DNA. The cDNA was synthesized from the DNaseI-treated
total RNA by MMLV reverse transcriptase (Invitrogen)
using oligo (dT) as a primer. The PCR reaction was carried
out as described above. Control samples without the reverse
transcriptase reaction were amplified in parallel to confirm
the absence of genomic DNA contamination. The PCR
products were fractionated on 1.5% agarose gel and ana-
lyzed by Southern blot analysis as described above. To
analyze the expression levels of IE180 and tTA mRNA in
the cerebellum of transgenic mice, quantitative RT-PCR
assays were carried out using 5-fold serial dilutions of the
cDNA samples. RT-PCR amplifications with the -actin
Fig. 9. Immunohistochemical analyses of the cerebella of a wild-type control
mouse (A and C) and a transgenic mouse of TgIE52 line (B and D). Immu-
nohistochemical staining of astrocytes with anti-GFAP antibody (A, B) and
Purkinje cells with anti-calbindin (CalD) antibody (C and D). GFAP-positive
bushy astrocytes and radial Bergmann glial cells are seen in the wild-type
cerebellum (A), while the bushy astrocytes and the Bergmann glial cells are
disorganized in the transgenic cerebellum (B). The precisely aligned Purkinje
cell layer and the branching Purkinje cell dendrites facing toward the cerebellar
surface are seen in the wild type cerebellum (C), while Purkinje cell bodies are
randomly oriented and immature dendritic arbor are seen in the transgenic
cerebellum (D). Scale bars: 100 m in A–D.
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specific primer pair (TK35 5-CGT GAA AAG ATG ACC
CAG-3, TK36 5-ATA GTG ATG ACC TGA CCG-3)
were also carried out as an internal control experiment. The
transgene expression was measured by scanning the agarose
gels using a FLUOR image analyzer (Fuji Film, Tokyo,
Japan) and then by densitometrical analysis of images using
Image Gauge Ver. 3.5 software (Fuji Film, Tokyo, Japan).
Footprint test
The footprint test (De Medinacell et al., 1982) was per-
formed to compare the gait of the transgenic mouse with
that of wild-type control mouse (8 weeks old). To obtain
their footprints, the hind- and forefeet of the mice were
coated with blue and red nontoxic paints, respectively. The
animals were then allowed to walk along a 35-cm-long,
9-cm-wide runway (with 6-cm-high walls). All mice had
three training runs and were then given a test run. A fresh
sheet of white paper was placed on the floor of the runway
for each run.
Rotarod test
A rotarod apparatus (Ugo Basile, Varese, Italy) was used
for measuring fore and hind limb motor coordination and
balance (Jones and Roberts, 1968). Each mouse (8 weeks
old) was placed on the rotarod at a constant speed (20 rpm)
for a maximum of 300 s, and the latency to falling off the
rotarod within this time period was recorded. Mice received
three trials per day, by which time a steady baseline level of
performance was attained. Data were evaluated using anal-
ysis of variance (ANOVA). All mean values are expressed
as mean  SD. For all analyses, significance was assigned
at the P  0.05 level.
Histological and immunohistochemical procedures
Various tissue samples from decapitated animals (8
weeks old) were excised and immersion-fixed in Bouin’s
solution for 24 h at room temperature, embedded in paraffin
wax and cut into 4 m-thick slices with a microtome. Some
sections were stained with hematoxylin and eosin, and oth-
ers were immunostained by the indirect immunoperoxidase
technique using antisera to glial fibrillary acidic protein
(GFAP) and calbindin. Immunohistochemistry was per-
formed as follows. Briefly, the rehydrated sections were
incubated with the following sera or solutions: (1) absolute
methanol containing 0.1% H2O2 for 30 min, (2) normal goat
serum diluted 1:100 for 1 h at room temperature, (3) anti-
calbindin diluted 1:2,000 or anti-GFAP (Dako) diluted 1:50
antiserum overnight at 4°C, (4) biotin-conjugated goat anti-
rabbit IgG antiserum diluted 1:100 for 1 h at room temper-
ature, (5) avidin-biotin complex diluted 1:100 (Vectastain
ABC kit, Vector Lab. Inc., Burlingame, USA), and finally
(6) 3,3-diaminobenzidine tetrahydrochloride-H2O2 solu-
tion for about 10 min. After immunohistochemistry, the
sections were lightly counterstained with hematoxylin, de-
hydrated and mounted with coverslips. The antiserum
against calbindin (Nakagawa et al., 1998) was kindly pro-
vided by Dr. M. Watanabe (Hokkaido University, Sapporo,
Japan).
Analysis of expression of cerebellar genes consistent with
the cerebellar phenotype
Transgenic and wild-type mice (postnatal day 0 or 9)
were killed by decapitation, and their cerebella were imme-
diately removed and frozen in liquid nitrogen. Total cellular
RNA was isolated as described above. To analyze expres-
sion of cerebellar genes that were consistent with the cere-
bellar phenotype, quantitative RT-PCR assays were carried
out as described above. The specific primers for the BLBP
gene (sense primer: 5-TTA TCA GTC AGG AAG GTG
GC-3, anti-sense primer: 5-TAAT TTT CTA CCT CCA
CAC CG-3), for the DAO gene (sense primer: 5-TTC
CCT GAT TAT GGC TAC GG-3, anti-sense primer: 5-
ATT CTC TTT CTA GCC GGA CC-3) for the IGFBP-1
gene (sense primer: 5-TTC TTG GCC GTT CCT GAT
TC-3, anti-sense primer: 5-TAT AGG TGC TGA TGG
CGT TC-3) and the tenascin gene (sense primer: 5-ACC
TGC TAC TGT GAA GAA GG-3, anti-sense: 5-TCA
TTG GGA CAG CTC ATC TC-3) were used for the
analyses. -actin specific primer pair was also used in an
internal control experiment. Expression levels of the genes
were measured as described above.
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